Maynard Um
-
-
-
-
-
-
-
This U.S. biotech stock is 'grossly undervalued', Bernstein says
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
'Our Top Pick Is Beam Therapeutics Inc (BEAM)'; PT Raised at Bernstein
-
-
-
-
-
-
-
Jefferies Starts Beam Therapeutics Inc (BEAM) at Buy
-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) gains on continued chatter
-
-
-
-
-
-
-
Beam, Inc. (BEAM) Misses Q1 EPS by 3c
-
-
-
-
-
-
-
Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
-
417,870 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

